|
|
||||||||||||||||||||||||||||||||||||||
By The Online Investor Staff, updated Mon., Nov. 17, 3:50 AM
|
|||||||||||||||||||||||||||||||||||||||
Secondary Stock Offerings| This Slide: #1 of 25 |
Slide #1. Fennec Pharmaceuticals Inc. — Secondary Offering
Company:
Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
Date announced:
11/13/2025
Secondary Offering Details:
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX.CA) ("Fennec" or the "Company"), a specialty pharmaceutical company, today announced that it intends to offer and sell its common shares in an underwritten registered public offering. In addition, Fennec intends to grant the underwriters a 30-day option to purchase up to an additional 15% of its common shares sold in the public offering.
Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration approved therapy indicated to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic, solid tumors.
Open the FENC Page at The Online Investor »
|
|||||||||||||||
Open the FENC Page at The Online Investor (in a new window) »
|
11/4/2025:
Company: NexPoint Real Estate Finance, Inc. (NREF)
Shares Offered: 8,000,000
More: offering details »
11/4/2025:
Company: Corebridge Financial, Inc. (CBRG)
Shares Offered: 32,600,000
More: offering details »
11/5/2025:
Company: Alpine Income Property Trust, Inc. (PINE)
Shares Offered: 2,000,000
More: offering details »
11/5/2025:
Company: First Watch Restaurant Group, Inc. (FWRG)
Shares Offered: 5,289,784
More: offering details »
11/5/2025:
Company: Benitec Biopharma Inc. (BNTC)
Shares Offered: 5,930,000
More: offering details »
11/5/2025:
Company: CCC Intelligent Solutions Holdings Inc. (CCC)
Shares Offered: 37,342,526
More: offering details »
11/6/2025:
Company: Intact Financial Corporation (IFC.CA)
Shares Offered: 6,000,000
More: offering details »
11/6/2025:
Company: BioHarvest Sciences Inc. (BHST)
Shares Offered: 2,485,000
More: offering details »
11/6/2025:
Company: Sotera Health Company (SHC)
Shares Offered: 30,000,000
More: offering details »
11/10/2025:
Company: Vor Biopharma Inc. (VOR)
Shares Offered: 10,000,000
More: offering details »
11/10/2025:
Company: Rollins, Inc. (ROL)
Shares Offered: 17,391,305
More: offering details »
11/10/2025:
Company: INOVIO Pharmaceuticals, Inc. (INO)
Shares Offered: 13,158,000
More: offering details »
11/11/2025:
Company: Centessa Pharmaceuticals plc (CNTA)
Shares Offered: 11,627,907
More: offering details »
11/11/2025:
Company: Biohaven Ltd. (BHVN)
Shares Offered: 23,333,334
More: offering details »
11/11/2025:
Company: Cogent Biosciences, Inc. (COGT)
Shares Offered: 9,677,420
More: offering details »
11/12/2025:
Company: DeFi Development Corp. (DFDV)
More: offering details »
11/12/2025:
Company: Kodiak Gas Services, Inc. (KGS)
Shares Offered: 10,000,000
More: offering details »
11/12/2025:
Company: enGene Holdings Inc. (ENGN)
More: offering details »
11/12/2025:
Company: Claritev Corporation (CTEV)
Shares Offered: 1,500,000
More: offering details »
11/12/2025:
Company: Inventiva (IVA)
Shares Offered: 38,961,038
More: offering details »
11/13/2025:
Company: Centuri Holdings, Inc. (CTRI)
Shares Offered: 7,441,860
More: offering details »
11/13/2025:
Company: Global Medical REIT Inc. (GMRE)
More: offering details »
11/13/2025:
Company: Power Corporation of Canada (POW.CA)
Shares Offered: 6,000,000
More: offering details »
11/13/2025:
Company: Verastem Oncology (VSTM)
More: offering details »
11/13/2025:
Company: Fennec Pharmaceuticals Inc. (FENC)
More: offering details »
 Free FENC Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Buy (3.33 out of 4) 59th percentile
(ranked higher than approx. 59% of all stocks covered)
Analysts' Target Price: FENC Stock Forecast Based on Zacks ABR data; via Quandl.com |
Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2025, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.